UK Approval For Seretide MDI: Cipla
Kedar Upadhye, global CFO of Cipla, says the company has received approval for the Seretide MDI inhaler. This is a market with a $200 million size as Cipla will be the second generics player in the UK market, he adds.
![[Sponsored] Samsung Galaxy Tab S10 FE+: A Game-Changer for Students](https://c.ndtvimg.com/2025-05/hkk372hk_image_160x120_03_May_25.png?downsize=355∶533 "[Sponsored] Samsung Galaxy Tab S10 FE+: A Game-Changer for Students")
